373 related articles for article (PubMed ID: 20025723)
1. Identifying significant genetic regulatory networks in the prostate cancer from microarray data based on transcription factor analysis and conditional independency.
Yeh HY; Cheng SW; Lin YC; Yeh CY; Lin SF; Soo VW
BMC Med Genomics; 2009 Dec; 2():70. PubMed ID: 20025723
[TBL] [Abstract][Full Text] [Related]
2. Transcription factor and microRNA regulation in androgen-dependent and -independent prostate cancer cells.
Wang G; Wang Y; Feng W; Wang X; Yang JY; Zhao Y; Wang Y; Liu Y
BMC Genomics; 2008 Sep; 9 Suppl 2(Suppl 2):S22. PubMed ID: 18831788
[TBL] [Abstract][Full Text] [Related]
3. Robust gene network analysis reveals alteration of the STAT5a network as a hallmark of prostate cancer.
Reddy A; Huang CC; Liu H; Delisi C; Nevalainen MT; Szalma S; Bhanot G
Genome Inform; 2010; 24():139-53. PubMed ID: 22081596
[TBL] [Abstract][Full Text] [Related]
4. Identification of open chromosomal regions and key genes in prostate cancer via integrated analysis of DNase‑seq and RNA‑seq data.
Wei X; Yu L; Jin X; Song L; Lv Y; Han Y
Mol Med Rep; 2018 Aug; 18(2):2245-2252. PubMed ID: 29956775
[TBL] [Abstract][Full Text] [Related]
5. ETS transcription factors control transcription of EZH2 and epigenetic silencing of the tumor suppressor gene Nkx3.1 in prostate cancer.
Kunderfranco P; Mello-Grand M; Cangemi R; Pellini S; Mensah A; Albertini V; Malek A; Chiorino G; Catapano CV; Carbone GM
PLoS One; 2010 May; 5(5):e10547. PubMed ID: 20479932
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide expression profiling reveals transcriptomic variation and perturbed gene networks in androgen-dependent and androgen-independent prostate cancer cells.
Singh AP; Bafna S; Chaudhary K; Venkatraman G; Smith L; Eudy JD; Johansson SL; Lin MF; Batra SK
Cancer Lett; 2008 Jan; 259(1):28-38. PubMed ID: 17977648
[TBL] [Abstract][Full Text] [Related]
7. Biochip analysis of prostate cancer.
Fan MQ; Wang PX; Feng JY; Xiao Y; Huang CB
Genet Mol Res; 2014 Jan; 13(1):152-9. PubMed ID: 24446298
[TBL] [Abstract][Full Text] [Related]
8. Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits.
Rhie SK; Guo Y; Tak YG; Yao L; Shen H; Coetzee GA; Laird PW; Farnham PJ
Epigenetics Chromatin; 2016; 9():50. PubMed ID: 27833659
[TBL] [Abstract][Full Text] [Related]
9. Cross-platform method for identifying candidate network biomarkers for prostate cancer.
Jin G; Zhou X; Cui K; Zhang XS; Chen L; Wong ST
IET Syst Biol; 2009 Nov; 3(6):505-12. PubMed ID: 19947776
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
[TBL] [Abstract][Full Text] [Related]
11. Construction of diagnosis system and gene regulatory networks based on microarray analysis.
Hong CF; Chen YC; Chen WC; Tu KC; Tsai MH; Chan YK; Yu SS
J Biomed Inform; 2018 May; 81():61-73. PubMed ID: 29550394
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA and Transcription Factor Gene Regulatory Network Analysis Reveals Key Regulatory Elements Associated with Prostate Cancer Progression.
Sadeghi M; Ranjbar B; Ganjalikhany MR; M Khan F; Schmitz U; Wolkenhauer O; Gupta SK
PLoS One; 2016; 11(12):e0168760. PubMed ID: 28005952
[TBL] [Abstract][Full Text] [Related]
13. A visual data mining tool that facilitates reconstruction of transcription regulatory networks.
Jupiter DC; VanBuren V
PLoS One; 2008 Mar; 3(3):e1717. PubMed ID: 18320038
[TBL] [Abstract][Full Text] [Related]
14. Constructing Bayesian networks by integrating gene expression and copy number data identifies NLGN4Y as a novel regulator of prostate cancer progression.
Gong Y; Wang L; Chippada-Venkata U; Dai X; Oh WK; Zhu J
Oncotarget; 2016 Oct; 7(42):68688-68707. PubMed ID: 27626693
[TBL] [Abstract][Full Text] [Related]
15. MICRAT: a novel algorithm for inferring gene regulatory networks using time series gene expression data.
Yang B; Xu Y; Maxwell A; Koh W; Gong P; Zhang C
BMC Syst Biol; 2018 Dec; 12(Suppl 7):115. PubMed ID: 30547796
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive gene expression microarray analysis of Ets-1 blockade in PC3 prostate cancer cells and correlations with prostate cancer tissues: Insights into genes involved in the metastatic cascade.
Adler D; Lindstrot A; Langer B; Buettner R; Wernert N
Int J Mol Med; 2011 Jun; 27(6):811-9. PubMed ID: 21424114
[TBL] [Abstract][Full Text] [Related]
17. Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer.
Ye Y; Li SL; Wang SY
PLoS One; 2018; 13(8):e0198055. PubMed ID: 30138363
[TBL] [Abstract][Full Text] [Related]
18. Identifying molecular features for prostate cancer with Gleason 7 based on microarray gene expression profiles.
Bălăcescu L; Bălăcescu O; Crişan N; Fetica B; Petruţ B; Bungărdean C; Rus M; Tudoran O; Meurice G; Irimie A; Dragoş N; Berindan-Neagoe I
Rom J Morphol Embryol; 2011; 52(4):1195-202. PubMed ID: 22203922
[TBL] [Abstract][Full Text] [Related]
19. Inferring large-scale gene regulatory networks using a low-order constraint-based algorithm.
Wang M; Augusto Benedito V; Xuechun Zhao P; Udvardi M
Mol Biosyst; 2010 Jun; 6(6):988-98. PubMed ID: 20485743
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional network modulated by the prognostic signature transcription factors and their long noncoding RNA partners in primary prostate cancer.
Jiang M; Cheng Y; Wang D; Lu Y; Gu S; Wang C; Huang Y; Li Y
EBioMedicine; 2021 Jan; 63():103150. PubMed ID: 33279858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
